OPS
VRTX icon

Orion Portfolio Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

Orion Portfolio Solutions’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$4.64M Buy
9,573
+610
+7% +$284K 0.05% 367
2024
Q4 		$3.61M Buy
8,963
+154
+2% +$71.4K 0.04% 428
2024
Q3 		$4.1M Sell
8,809
-710
-7% -$341K 0.04% 399
2024
Q2 		$4.46M Buy
9,519
+1,133
+14% +$492K 0.05% 343
2024
Q1 		$3.51M Sell
8,386
-1,623
-16% -$686K 0.04% 425
2023
Q4 		$4.19M Sell
10,009
-485
-5% -$179K 0.05% 344
2023
Q3 		$3.65M Sell
10,494
-1,048
-9% -$367K 0.04% 379
2023
Q2 		$4.06M Buy
11,542
+662
+6% +$223K 0.04% 374
2023
Q1 		$3.43M Buy
10,880
+8,523
+362% +$2.56M 0.04% 373
2022
Q4 		$681K Buy
2,357
+432
+22% +$132K 0.02% 406
2022
Q3 		$557K Buy
1,925
+302
+19% +$86.9K 0.02% 395
2022
Q2 		$457K Sell
1,623
-192
-11% -$51.4K 0.02% 425
2022
Q1 		$474K Sell
1,815
-379
-17% -$89.9K 0.02% 443
2021
Q4 		$482K Buy
2,194
+20
+0.9% +$3.89K 0.02% 437
2021
Q3 		$394K Buy
+2,174
New +$424K 0.01% 452
2021
Q2 		– Sell
-971
Closed -$209K – 638
2021
Q1 		$209K Sell
971
-377
-28% -$82.8K 0.01% 518
2020
Q4 		$319K Sell
1,348
-166
-11% -$38.1K 0.01% 382
2020
Q3 		$412K Buy
1,514
+342
+29% +$94.4K 0.02% 298
2020
Q2 		$340K Buy
1,172
+251
+27% +$68.1K 0.02% 300
2020
Q1 		$219K Buy
921
+112
+14% +$25.7K 0.02% 306
2019
Q4 		$177K Buy
+809
New +$164K 0.01% 328

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Orion Portfolio Solutions's VRTX Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Vertex Pharmaceuticals (VRTX) stake by 6.8% in Q1 2025, buying an estimated $284K and bringing the position to 9,573 shares worth $4.64M. The position accounts for 0.05% of the portfolio, ranked #367.

Orion Portfolio Solutions first reported a position in VRTX in Q4 2019 and has held it in 21 quarters since. 1,612 funds tracked by Wall St. Rank hold VRTX as of Q1 2025.

  • Orion Portfolio Solutions held 9,573 shares of Vertex Pharmaceuticals worth $4.64M as of Q1 2025.
  • Orion Portfolio Solutions bought 610 Vertex Pharmaceuticals shares in Q1 2025, an estimated $284K.
  • Vertex Pharmaceuticals made up 0.05% of Orion Portfolio Solutions's portfolio in Q1 2025, its #367 holding.
  • Orion Portfolio Solutions first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 21 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.